Bicycle Therapeutics Ltd
BCYC
$3.46-3.89%
End of day · as of Oct 17, 2026, 8:00 AM ET
Mkt cap
$554.03M
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
$72.59M
EPS (TTM)
$-2.73
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-301.66%
Beta
1.47
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Bicycle Therapeutics Ltd (BCYC) is a biotechnology company listed on US.
Latest reported BCYC revenue for 2025-12-31 was $72.6M. Net income was -$219.0M. Revenue was up 105.8% from 2024-12-31 to 2025-12-31. BCYC currently screens at market cap $554.0M.
Use this BCYC research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full BCYC income, balance, and cash tables.
Bicycle Therapeutics Ltd (BCYC) is a biotechnology company in the Healthcare sector.
Latest cached Bicycle Therapeutics Ltd (BCYC) revenue for Dec 31, 2025 was $72.6M. Net income was -$219.0M. Statements: https://lician.com/financials/bcyc
Bicycle Therapeutics Ltd (BCYC) market capitalization is $554.0M on the latest cached snapshot.
Bicycle Therapeutics Ltd (BCYC) cached previous close $3.60; day range $3.45 – $3.58; volume 550,619. Session quote: https://lician.com/quote/bcyc